The Healthcare Accreditation Colloquium announced that Texas Children's Hospital has earned the designation of Accredited Pediatric Heart Failure Institute following 12 months of work and an extensive onsite review.

 

August 15, 2014 — The National Institutes of Health (NIH) has launched the NIH 3-D Print Exchange, a public website that enables users to share, download and edit 3-D print files related to health and science. These files can be used, for example, to print custom laboratory equipment and models of bacteria and human anatomy.

August 15, 2014 — Mardil Medical announced earlier this year the first-in-human implants using the VenTouch ventricular reshaping device performed by a surgical team at the Institut Jantung Negara (IJN) National Heart Institute in Kuala Lumpur, Malaysia. This novel, investigational device was implanted in two patients with severe functional mitral valve regurgitation (FMR), which was reduced to only trace amounts after implantation. The patients are part of a multicenter, global clinical study.

August 15, 2014 — Zoll Medical Corp. announced its Japanese subsidiary, Asahi Kasei Zoll Medical (AZM), has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare to enter the Japanese market with its R Series monitor/defibrillator.

August 15, 2014 — Marking the 30th anniversary of the publication of their first joint guidelines for the diagnosis and treatment of heart disease, the American College of Cardiology (ACC) and the American Heart Association (AHA) published an extensive review of the process and methodology for evaluating cardiovascular research and writing practice guidelines for clinicians.


August 14, 2014 — Toshiba Medical Systems Europe will introduce the SURE Subtraction Coronary software at the 2014 European Society of Cardiology (ESC) Congress in Barcelona, to be held Aug. 30 to Sept. 3.

SunTech Medical acquired King’s College London’s central blood pressure technology as well as the assets of Centron Diagnostics Ltd., including the clinically-validated cBP301 Central Blood Pressure Monitor.

August 14, 2014 — New data from the Medtronic Inc. Adaptive CRT trial show a 61 percent (p=0.01) lower risk of atrial fibrillation (AF)-related problems in patients who receive a cardiac resynchronization therapy-defibrillator (CRT-D) with the Medtronic-exclusive AdaptivCRT algorithm compared to conventional biventricular pacing therapy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now